NAS:TSRO (USA) Also Trade In: Germany

Tesaro Inc $ 74.96 0 (0%)

Volume:
0
Avg Vol (1m):
0
Market Cap $:
4.13 Bil
Enterprise Value $:
-
P/E (TTM):
0.00
P/B:
0.00
Warning! GuruFocus has detected with TSRO. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for TSRO (Tesaro) from 2012 to Jul 12 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Tesaro stock (TSRO) PE ratio as of Jul 12 2020 is 0. More Details

Tesaro PE Ratio (TTM) Chart

EMBED

Tesaro PE Ratio (TTM) Historical Data

Total 865
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10
Tesaro PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-07-120.0 2018-11-230.0
2019-01-240.0 2018-11-220.0
2019-01-230.0 2018-11-210.0
2019-01-220.0 2018-11-200.0
2019-01-210.0 2018-11-190.0
2019-01-180.0 2018-11-160.0
2019-01-170.0 2018-11-150.0
2019-01-160.0 2018-11-140.0
2019-01-150.0 2018-11-130.0
2019-01-140.0 2018-11-120.0
2019-01-110.0 2018-11-090.0
2019-01-100.0 2018-11-080.0
2019-01-090.0 2018-11-070.0
2019-01-080.0 2018-11-060.0
2019-01-070.0 2018-11-050.0
2019-01-040.0 2018-11-020.0
2019-01-030.0 2018-11-010.0
2019-01-020.0 2018-10-310.0
2019-01-010.0 2018-10-300.0
2018-12-310.0 2018-10-290.0
2018-12-280.0 2018-10-260.0
2018-12-270.0 2018-10-250.0
2018-12-260.0 2018-10-240.0
2018-12-250.0 2018-10-230.0
2018-12-240.0 2018-10-220.0
2018-12-210.0 2018-10-190.0
2018-12-200.0 2018-10-180.0
2018-12-190.0 2018-10-170.0
2018-12-180.0 2018-10-160.0
2018-12-170.0 2018-10-150.0
2018-12-140.0 2018-10-120.0
2018-12-130.0 2018-10-110.0
2018-12-120.0 2018-10-100.0
2018-12-110.0 2018-10-090.0
2018-12-100.0 2018-10-080.0
2018-12-070.0 2018-10-050.0
2018-12-060.0 2018-10-040.0
2018-12-050.0 2018-10-030.0
2018-12-040.0 2018-10-020.0
2018-12-030.0 2018-10-010.0
2018-11-300.0 2018-09-280.0
2018-11-290.0 2018-09-270.0
2018-11-280.0 2018-09-260.0
2018-11-270.0 2018-09-250.0
2018-11-260.0 2018-09-240.0

Tesaro PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Biotechnology » Biotechnology NAICS : 325412 NAICS : 2834
Traded in other countries T8S.Germany TSRO.USA
Address
Tesaro is an oncology-focused biopharmaceutical company with a focus on developing treatments for cancer. Upon successful development and regulatory approval of any of its product candidates, the company intends to pursue commercialization in key product markets, including North America, Europe, and China. Tesaro is currently focused on commercializing products directly in North America, and directly or in partnership with established companies in Europe and China. The company's strategy is to identify, acquire, and develop promising drug candidates, and to commercialize cancer therapeutics that are potentially safer and more effective than existing treatments.